Table 1 Characteristics of the study population based on suicidal ideation
Characteristic | Total (n = 27944) | Non-suicidal ideation (n = 26907) | Suicidal ideation (n = 1037) | P value |
|---|---|---|---|---|
Age | 47.8 ± 18.6 | 47.8 ± 18.7 | 47.8 ± 18.0 | 0.981 |
Gender, % | < 0.001 | |||
Male | 14,092 (50.4) | 13,630 (50.7) | 462 (44.6) | |
Female | 13,852 (49.6) | 13,277 (49.3) | 575 (55.4) | |
Race, % | < 0.001 | |||
Mexican American | 4651 (16.6) | 4446 (16.5) | 205 (19.8) | |
Other Hispanic | 2681 (9.6) | 2513 (9.3) | 168 (16.2) | |
Non-Hispanic White | 12,343 (44.2) | 11,943 (44.4) | 400 (38.6) | |
Non-Hispanic Black | 5805 (20.8) | 5611 (20.9) | 194 (18.7) | |
Other Race | 2464 (8.8) | 2394 (8.9) | 70 (6.8) | |
Education level, % | < 0.001 | |||
Less than high school | 6488 (24.7) | 6106 (24.1) | 382 (39.3) | |
High school or above | 19,812 (75.3) | 19,221 (75.9) | 591 (60.7) | |
Marital, % | < 0.001 | |||
Married/living with partner | 16,716 (62.5) | 16,213 (62.9) | 503 (50.8) | |
Separated/divorced/widowed | 4943 (18.5) | 4689 (18.2) | 254 (25.6) | |
Never married | 5094 (19.0) | 4860 (18.9) | 234 (23.6) | |
MVPA, % | 0.142 | |||
Low (< 150 min per week) | 23,165 (82.9) | 22,306 (82.9) | 859 (84.3) | |
High (≥ 150 min per week) | 4779 (17.1) | 4601 (17.1) | 178 (15.7) | |
Alcohol status, n% | 0.267 | |||
Current or ever, % | 19,952 (71.4) | 19,238 (71.5) | 714 (69.9) | |
Never | 7992 (28.6) | 7669 (28.5) | 323 (30.1) | |
Smoking status, n% | < 0.001 | |||
Current or ever, % | 12,630 (45.2) | 12,054 (44.8) | 576 (55.3) | |
Never | 15,314 (54.8) | 14,853 (55.2) | 461 (44.7) | |
Hypertension, % | < 0.001 | |||
Yes | 9561 (34.2) | 9123 (33.9) | 438 (42.2) | |
No | 18,383 (65.8) | 17,784 (66.1) | 599 (57.8) | |
Diabetes, % | < 0.001 | |||
Yes | 3880 (13.9) | 3669 (13.6) | 211 (20.3) | |
No | 24,064 (86.1) | 23,238 (86.4) | 826 (79.7) | |
Hyperlipidemia, % | 0.002 | |||
Yes | 19,576 (70.1) | 18,805 (69.9) | 771 (74.3) | |
No | 8368 (29.9) | 8102 (30.1) | 266 (25.7) | |
CHD, % | < 0.001 | |||
Yes | 1064 (4.1) | 993 (3.9) | 71 (7.3) | |
No | 25,158 (95.9) | 24,260 (96.1) | 898 (92.7) | |
Stroke | < 0.001 | |||
Yes | 929 (3.5) | 853 (3.4) | 76 (7.8) | |
No | 25,356 (96.5) | 24,460 (96.6) | 896 (92.2) | |
Cancer, % | 0.057 | |||
Yes | 2490 (9.5) | 2381 (9.4) | 109 (11.2) | |
No | 23,802 (90.5) | 22,940 (90.6) | 862 (88.8) | |
Body mass index, kg/m2 | 29.0 ± 6.9 | 29.0 ± 6.9 | 29.8 ± 7.8 | < 0.001 |
Albumin, g/dl | 42.7 ± 3.3 | 42.7 ± 3.3 | 42.2 ± 3.7 | < 0.001 |
Creatinine, umol/L | 80.3 ± 38.7 | 80.3 ± 38.9 | 79.2 ± 34.5 | 0.354 |
PIR | 2.51 ± 1.63 | 2.54 ± 1.63 | 1.71 ± 1.38 | < 0.001 |
CRP | 0.19 (0.07, 0.44) | 0.19 (0.07, 0.44) | 0.21 (0.08, 0.60) | 0.008 |
Total energy intake, kcal/d | 2124.7 ± 1004.0 | 2127.0 ± 1001.5 | 2065.3 ± 1066.9 | 0.053 |
Omega-3 fatty acids intake, g/d | 1.45 (0.90, 2.27) | 1.46 (0.90, 2.28) | 1.23 (0.74, 2.03) | < 0.001 |
Omega-6 fatty acids intake, g/d | 13.79 (8.61, 20.95) | 13.83 (8.66, 21.01) | 12.30 (7.11, 19.70) | < 0.001 |
Omega-6/3 fatty acids intake ratio | 9.10 (7.53, 11.41) | 9.10 (7.53, 11.40) | 9.28 (7.58, 12.00) | 0.020 |